Spinal Muscular Atrophy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: DNA samples from patients having SMA under the written consent for research use covering the current study
Exclusion criteria
Exclusion criteria: DNA samples from patients who were confirmed without SMA DNA samples without demographic data including age, SMA type, age at onset and maximum and current motor function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigate theSMN1 gene deletions/mutations throughout Exon/Intron 1 to 8 in types III/IV SMA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigate theSMN1 gene deletions/mutations throughout Exon/Intron 1 to 8 in types I/II 5qSMA. | — |
Countries
Japan
Contacts
Tokyo Women's Medical University Institute of Medical Genetics